{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T06:14:16Z","timestamp":1698387256108},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":4863,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Toxicology"],"published-print":{"date-parts":[[1995,12]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> 5\u2010Lipoxygenase products of arachidonic acid metabolism are thought to play a central role in the secondary amplification of the inflammatory response of several inflammatory diseases, including ulcerative colitis. FPL 64170XX is a selective inhibitor of the enzyme 5\u2010lipoxygenase. Concentrations of leukotriene B<jats:sub>4<\/jats:sub> and prostaglanding E<jats:sub>2<\/jats:sub> in rectal dialysis fluid from 23 males with clinically and sigmoidoscopically active, distally located ulcerative colitis were measured by radioimmunoassays in a double\u2010blind, placebo\u2010controlled, parallel design study before and after rectal administration of an enema containing 0.5% of FPL 64170XX. Repeated measures analysis of leukotriene B<jats:sub>4<\/jats:sub>, after adjusting for baseline, showed a significant treatment effect (P=0.0014). The concentration of leukotriene B<jats:sub>4<\/jats:sub> from rectal dialysates in patients receiving the active drug dropped to 15% (95% confidence interval 5\u201340%) of the placebo level in the second dialysis following administration of FPL 64170XX 0.5%. By contrast, prostaglanding E<jats:sub>2<\/jats:sub> concentrations doubled (P=0.0068) in patients receiving FPL 64170XX 0.5% with no change in the placebo group. These findings demonstrate that a single dose of FPL 64170XX 0.5% enema selectively blocks the generation of the 5\u2010lipoxygenase product, leukotriene B<jats:sub>4<\/jats:sub>, to a mean of 85% in the target tissue of inflammation. Topical administration of this new leukotriene synthesis inhibitor may prove to be a clinically useful approach to the treatment of active, distally located ulcerative colitis.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1995.tb01044.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T16:59:59Z","timestamp":1238000399000},"page":"371-376","source":"Crossref","is-referenced-by-count":5,"title":["Selective Blockade of Leukotriene Production by a Single Dose of the FPL 64170XX 0.5% Enema in Active Ulcerative Colitis"],"prefix":"10.1111","volume":"77","author":[{"given":"Jens","family":"Kjeldsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurits St\u00e6rk","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Hillingse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Mertz\u2010Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Bukhave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen","family":"Rask\u2010Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0016-5085(82)80190-X","article-title":"Incidence and prevalence of ulcerative colitis and Crohn's disease in the county of Copenhagen, 1962 to 1978","volume":"83","author":"Binder V.","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/S0021-9258(19)69199-4","article-title":"Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes","volume":"256","author":"Bokoch G. M.","year":"1981","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1981.tb01840.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200100406"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/286264a0"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.11.1271"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90684-0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.9.1095"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90284-3"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646865"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90803-D"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199403000-00004"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.6.3710"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)91210-3"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01965001"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365527809182199"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(79)90052-2"},{"key":"e_1_2_1_19_1","volume-title":"SAS, Campus Drive","author":"SAS v 6.07"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0016-5085(84)80015-3","article-title":"Enhanced synthesis of leukotriene B4 by chronic mucosa in inflammatory bowel disease","volume":"86","author":"Sharon P.","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1980.tb12985.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110474"},{"key":"e_1_2_1_23_1","unstructured":"Statistic v 4.0 Analytical Software.1958Eldridge Avenue P.O. Box 130204 St. Paul MN 55113 USA."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199303000-00001"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90760-9"}],"container-title":["Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1995.tb01044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1995.tb01044.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T02:46:06Z","timestamp":1698288366000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1995.tb01044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1111\/j.1600-0773.1995.tb01044.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1995.tb01044.x","archive":["Portico"],"relation":{},"ISSN":["0901-9928"],"issn-type":[{"value":"0901-9928","type":"print"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}